Pediatric and Adolescent Nephrology Facing the Future: Diagnostic Advances and Prognostic Biomarkers in Everyday Practice
The Special Issue entitled "Pediatric and adolescent nephrology facing the future: diagnostic advances and prognostic biomarkers in everyday practice" contains articles written in the era when COVID-19 had not yet been a major clinical problem in children. Now that we know its multifaceted...
Format: | eBook |
---|---|
Language: | English |
Published: |
Basel
MDPI - Multidisciplinary Digital Publishing Institute
2022
|
Subjects: | |
Online Access: | Open Access: DOAB: description of the publication Open Access: DOAB, download the publication |
LEADER | 05343namaa2201525uu 4500 | ||
---|---|---|---|
001 | doab95834 | ||
003 | oapen | ||
005 | 20230105 | ||
006 | m o d | ||
007 | cr|mn|---annan | ||
008 | 230105s2022 xx |||||o ||| 0|eng d | ||
020 | |a 9783036559735 | ||
020 | |a 9783036559742 | ||
020 | |a books978-3-0365-5974-2 | ||
024 | 7 | |a 10.3390/books978-3-0365-5974-2 |2 doi | |
040 | |a oapen |c oapen | ||
041 | 0 | |a eng | |
042 | |a dc | ||
072 | 7 | |a M |2 bicssc | |
072 | 7 | |a MJ |2 bicssc | |
720 | 1 | |a Taranta-Janusz, Katarzyna |4 edt | |
720 | 1 | |a Musiał, Kinga |4 edt | |
720 | 1 | |a Musiał, Kinga |4 oth | |
720 | 1 | |a Taranta-Janusz, Katarzyna |4 oth | |
245 | 0 | 0 | |a Pediatric and Adolescent Nephrology Facing the Future: Diagnostic Advances and Prognostic Biomarkers in Everyday Practice |
260 | |a Basel |b MDPI - Multidisciplinary Digital Publishing Institute |c 2022 | ||
300 | |a 1 online resource (304 p.) | ||
336 | |a text |b txt |2 rdacontent | ||
337 | |a computer |b c |2 rdamedia | ||
338 | |a online resource |b cr |2 rdacarrier | ||
506 | 0 | |a Open Access |f Unrestricted online access |2 star | |
520 | |a The Special Issue entitled "Pediatric and adolescent nephrology facing the future: diagnostic advances and prognostic biomarkers in everyday practice" contains articles written in the era when COVID-19 had not yet been a major clinical problem in children. Now that we know its multifaceted clinical course, complications concerning the kidneys, and childhood-specific post-COVID pediatric inflammatory multisystem syndrome (PIMS), the value of diagnostic and prognostic biomarkers in the pediatric area should be appreciated, and their importance ought to increase. | ||
540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |u https://creativecommons.org/licenses/by/4.0/ | ||
546 | |a English | ||
650 | 7 | |a Clinical and internal medicine |2 bicssc | |
650 | 7 | |a Medicine and Nursing |2 bicssc | |
653 | |a [IGFBP-7] × [TIMP-2] | ||
653 | |a adenine nucleotide metabolites | ||
653 | |a adolescents | ||
653 | |a alpha-1 acid glycoprotein | ||
653 | |a antibiotic resistance | ||
653 | |a arterial damage | ||
653 | |a artificial intelligence | ||
653 | |a B2M | ||
653 | |a biomarker | ||
653 | |a blood pressure | ||
653 | |a bone morphogenetic protein (BMP)-2 | ||
653 | |a bone morphogenetic protein (BMP)-6 | ||
653 | |a cancer | ||
653 | |a cardiovascular disease | ||
653 | |a cathepsin B | ||
653 | |a CCS | ||
653 | |a childhood | ||
653 | |a children | ||
653 | |a chronic kidney disease | ||
653 | |a chronic renal failure | ||
653 | |a CKD | ||
653 | |a common carotid artery intima-media thickness | ||
653 | |a congenital obstructive nephropathy | ||
653 | |a cystatin C | ||
653 | |a cytokeratin-18 | ||
653 | |a cytokines | ||
653 | |a dental caries | ||
653 | |a diabetic kidney disease | ||
653 | |a eGFR | ||
653 | |a endoglin | ||
653 | |a Escherichia coli | ||
653 | |a extracellular matrix metalloproteinases inducer (EMMPRIN) | ||
653 | |a FEUA | ||
653 | |a furosemide stress test | ||
653 | |a galectin-3 | ||
653 | |a gingivitis | ||
653 | |a glomerular injury | ||
653 | |a glomerulopathy | ||
653 | |a hemopexin | ||
653 | |a HNF1B | ||
653 | |a hyperfiltration | ||
653 | |a hyperuricemia | ||
653 | |a IgA nephropathy | ||
653 | |a IgA vasculitis with nephritis | ||
653 | |a immaturity | ||
653 | |a infection | ||
653 | |a inflammatory markers | ||
653 | |a kidney injury | ||
653 | |a machine learning | ||
653 | |a macrophage migration inhibitory factor (MIF) | ||
653 | |a markers | ||
653 | |a medical decision support system | ||
653 | |a myelomeningocele | ||
653 | |a n/a | ||
653 | |a nephropathies | ||
653 | |a nephrotic syndrome | ||
653 | |a netrin-1 | ||
653 | |a neurogenic bladder | ||
653 | |a neurotrophins | ||
653 | |a NGAL | ||
653 | |a NT-proBNP | ||
653 | |a obesity | ||
653 | |a overactive bladder | ||
653 | |a periostin | ||
653 | |a premature neonates | ||
653 | |a premature newborns | ||
653 | |a primary hypertension | ||
653 | |a PTH | ||
653 | |a renal angina index | ||
653 | |a renal fibrosis | ||
653 | |a renal function | ||
653 | |a renal functional reserve | ||
653 | |a renal toxicity | ||
653 | |a renal tubular damage | ||
653 | |a sclerostin | ||
653 | |a solitary functioning kidney | ||
653 | |a transcutaneous electrical nerve stimulation | ||
653 | |a transforming growth factor-β1 | ||
653 | |a tubular damage | ||
653 | |a tubular functional reserve | ||
653 | |a tubuloglomerular feedback | ||
653 | |a tumor necrosis factor-like weak inducer of apoptosis | ||
653 | |a uric acid | ||
653 | |a urinary microbiome | ||
653 | |a urinary mRNA expression of podocyte-associated proteins | ||
653 | |a urinary tract | ||
653 | |a urinary tract infection | ||
653 | |a urinary tract infections | ||
653 | |a vanin-1 | ||
653 | |a vascular endothelial markers | ||
653 | |a voiding cystography | ||
793 | 0 | |a DOAB Library. | |
856 | 4 | 0 | |u https://directory.doabooks.org/handle/20.500.12854/95834 |7 0 |z Open Access: DOAB: description of the publication |
856 | 4 | 0 | |u https://mdpi.com/books/pdfview/book/6490 |7 0 |z Open Access: DOAB, download the publication |